[Spring meeting of the French Federation of Digestive Oncology, co-organized with the French Cancer Society. Clermont-Ferrand, June 22, 2007].
Auvray
Hugues
H
Centre Jean-Perrin, Clermont-Ferrand.
D000911:Antibodies, Monoclonal / Q000009:adverse effects; D003131:Combined Modality Therapy / Q000379:methods; D003362:Cost-Benefit Analysis; D004059:Diffusion of Innovation; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D004938:Esophageal Neoplasms / Q000628:therapy; D005602:France; D006801:Humans; D008495:Medical Oncology; D009363:Neoplasm Proteins / Q000378:metabolism; D009369:Neoplasms / Q000191:economics / Q000378:metabolism / Q000628:therapy; D018529:Nutritional Support; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000601:surgery; D012955:Societies, Medical
D000911:Antibodies, Monoclonal; D009363:Neoplasm Proteins; D066246:ErbB Receptors